Latest Articles
Evidence for KISS-1 nuclear translocation and PI3K/AKT signaling in the ultrastructurally and morphometrically analyzed human endometriosis.
Endometriosis is a common estrogen-dependent disease marked by ectopic endometrial growth. Although the PI3K/AKT and kisspeptin pathways are known to regulate endometrial homeostasis, their interplay in disease progression remains unclear. …
Published: Jan. 6, 2026, midnight
Artificial Intelligence in Gynecologic Imaging.
What was done? A review of artificial intelligence (AI) applications for the imaging of uterine fibroids, endometriosis, and adenomyosis. What was found? AI models can assist with the recognition, segmentation, …
Published: Jan. 6, 2026, midnight
Nine common conditions to be managed via new NHS online hospital - The Independent
Nine common conditions to be managed via new NHS online hospital The Independent
Published: Jan. 5, 2026, 10:30 p.m.
Patients to access specialists via NHS online hospitals - see list of conditions - The Mirror
Patients to access specialists via NHS online hospitals - see list of conditions The Mirror
Published: Jan. 5, 2026, 10:30 p.m.
Neuroscience drugmaker CEO to speak at J.P. Morgan healthcare event - Stock Titan
Neuroscience drugmaker CEO to speak at J.P. Morgan healthcare event Stock Titan
Published: Jan. 5, 2026, 9:01 p.m.
Petition against introduction of digital ID cards most signed in Hemel Hempstead constituency - Hemel Today
Petition against introduction of digital ID cards most signed in Hemel Hempstead constituency Hemel Today
Published: Jan. 5, 2026, 3:43 p.m.
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice - Targeted Oncology
Using Lenvatinib/Pembrolizumab for Endometrial Cancer in Clinical Practice Targeted Oncology
Published: Jan. 5, 2026, 1:27 p.m.
Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer - Targeted Oncology
Real-World Results for Lenvatinib Plus Pembrolizumab in Endometrial Cancer Targeted Oncology
Published: Jan. 5, 2026, 1:12 p.m.
Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadjuvant/Adjuvant Therapy - Targeted Oncology
Lenvatinib Plus Pembrolizumab in Endometrial Cancer After Neoadjuvant/Adjuvant Therapy Targeted Oncology
Published: Jan. 5, 2026, 1:07 p.m.
Petition urges Government to introduce menstrual leave - FemTech World
Petition urges Government to introduce menstrual leave FemTech World
Published: Jan. 5, 2026, 9:10 a.m.
Link copied to clipboard!